Campbell & Co Investment Adviser’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-718
| Closed | -$222K | – | 1209 |
|
2024
Q4 | $222K | Buy |
+718
| New | +$222K | 0.02% | 941 |
|
2023
Q4 | – | Sell |
-6,571
| Closed | -$960K | – | 1238 |
|
2023
Q3 | $960K | Buy |
+6,571
| New | +$960K | 0.11% | 282 |
|
2023
Q1 | – | Sell |
-1,438
| Closed | -$417K | – | 939 |
|
2022
Q4 | $417K | Buy |
+1,438
| New | +$417K | 0.1% | 397 |
|
2022
Q2 | – | Sell |
-13,196
| Closed | -$1.3M | – | 820 |
|
2022
Q1 | $1.3M | Buy |
+13,196
| New | +$1.3M | 0.35% | 42 |
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$399K | – | 734 |
|
2021
Q3 | $399K | Buy |
+5,000
| New | +$399K | 0.13% | 284 |
|